News
Why Corcept Therapeutics’ Relacorilant Fell Short And What It Means For The Company
This article was written byFollowBioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible,…
Editor's Top Picks
Goldman Sachs Emerging Markets Equity Insights Fund Q3 2025 Commentary
Market Review In the third quarter of 2025, the MSCI Emerging Markets Index rose by 10.64%, contributing to the strongest…
Your one-stop resource for personal news and tips.
More form News
Innoviz Stock: Deep Dive Into LiDAR Leader Of The Future (INVZ)
This article was first posted in Outperforming the Market on June 2, 2023. This article…
Turkey’s new finance team faces huge challenge to fix economy
Steering Turkey towards a sustainable economic path will require a sharp rise in borrowing costs…
SPY ETF: The Fed Likely To Cap The Bear Market Rally
First, let's me point that, based on my analysis, the recent breach of the 20%…
French AI fundraising sensation shows Europe’s got talent
They have a business concept, prestigious French engineering degrees, stints at US tech groups and…
Adobe: Our Favorite AI Stock Right Now (NASDAQ:ADBE)
Adobe Inc. (NASDAQ:ADBE) has quickly cemented itself a leader in generative AI tools geared toward…
Americans are staying right where they are
You would be forgiven for assuming that the US was in the middle of a…
Amazon’s Silent AI Revolution: Rethinking AWS’ Growth (NASDAQ:AMZN)
Investment Thesis With the AI rally underway and companies like Nvidia (NVDA) posting a 195%…
Why China’s economic recovery is hanging in the balance
Five months after China’s president Xi Jinping declared victory over the pandemic and relaxed stringent…
June FOMC Meeting: A Very Hawkish Pause
By Seema Shah At Wednesday’s meeting, for the first time since March 2022, the Federal…
Micron to invest $600mn in Chinese factory despite Beijing ban
Micron plans to invest more than $600mn in its factory in the Chinese city of…
XRMI: Risk Managed S&P 500 Return, Not Worth The Trouble
Thesis The Global X S&P 500 Risk Managed Income ETF (NYSEARCA:XRMI) is a fairly new…
Nissan’s internal leadership clash forces top executive’s exit
A bitter clash among the top leadership of Nissan has forced out an executive previously…
It’s A Coin Toss: Gold And Silver Analysis
By David Brady The Fed paused rate hikes on Wednesday but stated its intention to…
US bank regulator begins $460mn sale of SVB’s German assets
The US banking regulator has kicked off the sale of collapsed Silicon Valley Bank’s German…
ADMA Biologics: Adding Intrinsic Value Based On The Catalysts
Investment Summary A full 6-months have passed since my buy thesis on ADMA Biologics, Inc.…